EUVIMEDEUVIMED entdecken
Crossref

Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment

Jie Wang, Guangting Zhu, Yunxiang Ding, Ming Lei, Xuan Yan, Qingjian Lei, Sang Hu, Lin Cai, Feifei Yan

ACS Nano · 13.11.2026

DOI: 10.1021/acsnano.6c15131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 13.11.2026. Verfasst von Jie Wang und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Zhongnan Hospital of Wuhan University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer bone metastasis remains a major therapeutic challenge due to endoplasmic reticulum stress (ERS)-associated stress adaptation and an immunosuppressive tumor immune microenvironment (TIME). Herein, we report a zoledronic acid (ZOL)-loaded bone-targeted covalent piezoelectric heterojunction nanoplatform (Z@BT-P) for sonopiezo-dynamic therapy (SPDT) and immune remodeling. In this platform, barium titanate (BTO) was covalently integrated with a porphyrinic porous coordination network to form a stable BT-P heterointerface, while ZOL enhanced bone-metastatic lesion enrichment. Compared with physically assembled BT@P, Z@BT-P promoted interfacial charge utilization and strengthened ultrasound (US)-triggered piezoelectric catalysis. Under US irradiation, enhanced charge utilization and Piezo1-associated mechanosensitive Ca2+ signaling jointly amplified reactive oxygen species accumulation and Ca2+ dysregulation, causing dual oxidative/Ca2+ stress. This stress cascade promoted ERS associated with glucose-regulated protein 78 and C/EBP homologous protein, leading to apoptosis and immunogenic cell death. Consequent damage-associated molecular patterns release and ZOL-containing treatment enhanced dendritic cell maturation, drove M1-like macrophage remodeling, and activated antitumor immunity. In a 4T1-luc tibial bone metastasis model, Z@BT-P + US achieved 89.4% ± 4.9% tumor growth inhibition, alleviated osteolytic bone destruction, suppressed distant metastasis, and promoted immune memory. This study establishes a covalent interface-engineered piezoelectric nanoplatform for bone metastasis therapy.

Förderung

  • Zhongnan Hospital of Wuhan University

Zitieren

APA

Wang, J., Zhu, G., Ding, Y., Lei, M., Yan, X., Lei, Q., Hu, S., Cai, L., & Yan, F. (2026). Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment. ACS Nano. https://doi.org/10.1021/acsnano.6c15131

Vancouver

Wang J, Zhu G, Ding Y, Lei M, Yan X, Lei Q, et al. Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment. ACS Nano. 2026. doi:10.1021/acsnano.6c15131

BibTeX
@article{Wang2026,
  author = {Wang, Jie and Zhu, Guangting and Ding, Yunxiang and Lei, Ming and Yan, Xuan and Lei, Qingjian and Hu, Sang and Cai, Lin and Yan, Feifei},
  title = {Covalent Interface-Engineered Bone-Targeting Piezoelectric Heterojunction Reprograms Tumor Stress Adaptation and Reverses the Immunosuppressive Microenvironment},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c15131}
}
Kostenlos starten →